Semaglutide is perfectly tolerated without danger of hypoglycaemia in monotherapy but suffers from gastrointestinal adverse consequences. A substantial population influenced with COVID-19 an infection were diabetic; thus use of semaglutide in diabetes together with CV people can be a great deal supportive in protecting health and fitness care procedure in https://actono554wju9.wikicommunication.com/user